Some Insurance Companies Restrict Access to Less Addictive Pain Medications


Some insurance companies are restricting patients’ access to pain medicines with a lower risk of dependence or addiction, while making it easier to get generic opioid drugs, The New York Times reports.

Opioids drugs are generally less expensive than safer alternatives, the article notes.

The New York Times and ProPublica analyzed Medicare prescription drug plans covering 35.7 million people.

They found only one-third of people had access to Butrans, a painkilling skin patch containing buprenorphine, a less-risky opioid. Every drug plan that covered lidocaine patches, which are not addictive, but are more expensive than other generic pain drugs, required that patients get prior approval for the patches.

Almost all plans covered common opioids, and few plans required patients to obtain prior approval for them.

Related Posts

Thank you for visiting Facing Addiction with NCADD

For 24-hour free and confidential referrals and information about mental and/or substance use disorders, prevention, treatment, and recovery in English and Spanish, please call the SAMSHA national help line: 1-800-662-HELP (4357)


For referral information and other resources, please visit the Recovery Resource Hub